首页> 外文期刊>Journal of Gastrointestinal Oncology >Differential analysis of RNA methylation regulators in gastric cancer based on TCGA data set and construction of a prognostic model
【24h】

Differential analysis of RNA methylation regulators in gastric cancer based on TCGA data set and construction of a prognostic model

机译:基于TCGA数据集的胃癌RNA甲基化调节剂的差异分析及预后模型的构建

获取原文
       

摘要

Background: Methylation is one of the common forms of RNA modification, which mainly include N6-methyladenosine (m6A), C5-methylcytidine (m5C), and N1-methyladenosine (m1A). Numerous studies have shown that RNA methylation is associated with tumor development. We aim to construct prognostic models of gastric cancer based on RNA methylation regulators. Methods: The transcriptome and clinical data of gastric cancer and normal samples were obtained from the National Cancer Institute Genome Data Commons (NCI-GDC). Use Least Absolute Shrinkage and Selection Operator (LASSO) Cox regression analysis to construct risk models for different types of RNA methylation. Receiver operating characteristic (ROC) curves were generated to evaluate the predictive efficiency of risk characteristics. Cluster heat maps are used to assess the correlation with clinical information. Univariate and multivariate Cox analyses were used to analyze prognostic effects of risk scores. Gene Set Enrichment Analysis (GSEA) analyzes the functional enrichment of RNA methylation genes. And make a separate analysis of the data of Asians. Results: The expression of most of the 30 RNA methylation regulators were significantly different in cancer and paracancerous tissues (P0.05). Three methylated genes ( FTO , ALKBH5 , and RBM15 ) were screened from m6A by LASSO Cox regression analysis. Five methylated genes ( FTO , ALKBH5 , TRMT61B , RBM15 , and YXB1 ) were selected from the population, and were used to construct two risk ratio models. Survival analysis showed that the survival rate of patients in the low-risk group was significantly higher than that in the high-risk group (P0.05). All ROC curves indicated that the predictive efficiency of risk characteristics was good [area under the ROC curve (AUC): 0.6–1].Cluster analysis reveals differences in clinical data between the two groups. Univariate and multivariate Cox regression results show that the risk score has independent prognostic value. GSEA showed that pathways such as cell cycle were significantly enriched in the low-risk group, while pathways such as calcium signaling pathway were significantly enriched in the high-risk group. In addition, three methylation models that can predict the prognosis of Asian gastric cancer patients were obtained. Conclusions: The methylation prognosis model constructed in this study can effectively predict the prognosis of gastric cancer patients.
机译:背景:甲基化是RNA改性的常见形式之一,其主要包括N6-甲基碳糖苷(M6a),C5-甲基胞苷(M5℃)和N1-甲基腺苷(M1A)。许多研究表明RNA甲基化与肿瘤发育有关。我们的目标是基于RNA甲基化调节剂构建胃癌的预后模型。方法:从国家癌症研究所基因组数据公共(NCI-GDC)获得了胃癌和正常样品的转录组和临床数据。使用最不绝对的收缩和选择操作员(套索)Cox回归分析,构建不同类型的RNA甲基化的风险模型。产生接收器操作特征(ROC)曲线以评估风险特征的预测效率。群集热图用于评估与临床信息的相关性。单变量和多变量的COX分析用于分析风险评分的预后效果。基因设定富集分析(GSEA)分析RNA甲基化基因的功能性富集。并对亚洲人数据进行单独分析。结果:大多数30个RNA甲基化调节剂的表达在癌症和副癌组织中显着不同(P <0.05)。通过载体COX回归分析从M6A筛选三种甲基化基因(FTO,ALKBH5和RBM15)。选自五种甲基化基因(FTO,ALKBH5,TRMT61B,RBM15和YXB1),并用于构建两个风险比模型。生存分析表明,低风险组患者的存活率明显高于高风险组(P <0.05)。所有ROC曲线表明风险特征的预测效率很好[ROC曲线下的面积(AUC):0.6-1] .Cluster分析显示两组之间的临床数据的差异。单变量和多元COX回归结果表明,风险评分具有独立的预后价值。 GSEA表明,在低风险组中显着富集了诸如细胞周期的途径,而钙信号通路的途径在高风险群体中显着富集。此外,获得了三种可以预测亚洲胃癌患者预后的甲基化模型。结论:本研究中构建的甲基化预后模型可以有效预测胃癌患者的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号